Article

Effect of EGF dosage forms on alkali burned corneal wound healing of mice.

Department of Physiology, Gazi University Faculty of Medicine, Ankara, Turkey.
Burns (impact factor: 1.96). 03/1995; 21(1):7-10. DOI:10.1016/0305-4179(95)90773-S
Source: PubMed

ABSTRACT The local treatment effects of EGF forms on alkali burned mice corneal wounds were identified. The corneal wounds were induced by 0.5 M NaOH solution on the corneal surfaces of the mice. The local epidermal growth factor solutions (100 ng/ml) and gel form in 0.2 per cent w/w carbopol 940 (100 ng/ml) were dropped in 5 microliters aliquots into the eye twice a day. The corneal wounds were measured for 15 days at 7-day intervals and examined histologically at the end of 15th day of the experimental period. The results indicated that topical epidermal growth factor treatment in solution improved the healing of alkali burned corneal wounds when compared with epidermal growth factor delivered in a polymer system.

0 0
 · 
0 Bookmarks
 · 
19 Views
  • Source
    Article: Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.
    John S Graham, Robert P Chilcott, Paul Rice, Stephen M Milner, Charles G Hurst, Beverly I Maliner
    [show abstract] [hide abstract]
    ABSTRACT: Sulfur mustard is an alkylating chemical warfare agent that primarily affects the eyes, skin, and airways. Sulfur mustard injuries can take several months to heal, necessitate lengthy hospitalizations, and result in significant cosmetic and/or functional deficits. Historically, blister aspiration and/or deroofing (epidermal removal), physical debridement, irrigation, topical antibiotics, and sterile dressings have been the main courses of action in the medical management of cutaneous sulfur mustard injuries. Current treatment strategy consists of symptomatic management and is designed to relieve symptoms, prevent infections, and promote healing. There are currently no standardized or optimized methods of casualty management that prevent or minimize deficits and provide for speedy wound healing. Several laboratories are actively searching for improved therapies for cutaneous vesicant injury, with the aim of returning damaged skin to optimal appearance and normal function in the shortest time. Improved treatment will result in a better cosmetic and functional outcome for the patient, and will enable the casualty to return to normal activities sooner. This editorial gives brief overviews of sulfur mustard use, its toxicity, concepts for medical countermeasures, current treatments, and strategies for the development of improved therapies.
    Journal of burns and wounds 02/2005; 4:e1.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

7-day intervals
 
cent w/w carbopol 940
 
corneal wounds
 
EGF forms
 
epidermal growth factor
 
gel form
 
histologically
 
local epidermal growth factor solutions
 
local treatment effects
 
M NaOH solution
 
mice corneal wounds
 
polymer system
 
topical epidermal growth factor treatment